Becton Dickinson falls after missing revenue estimates
** Medical device maker Becton Dickinson's BDX.N shares fall 6.4% to $170 in premarket trading ** Co's quarterly revenue of $5.89 billion beats analysts' average expectation of $5.90 billion ** Co reports Q4 adj.profit of $3.96/shr vs analysts' average estimate of $3.92/shr - LSEG data ** Up to last close, stock down ~23% YTD (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com))
Recent news on Becton Dickinson and
See all newsBrief: Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Becton Dickinson rises after pledging $19 billion US investment for tariff relief
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Becton Dickinson To Invest $19 billion In US